Order Article Reprints

Li Y, Li Y, Chen N, Feng L, Gao J, Zeng N, He Z, Gong Q. Icariside II Exerts Anti-Type 2 Diabetic Effect by Targeting PPARα/γ: Involvement of ROS/NF-κB/IRS1 Signaling Pathway. Antioxidants. 2022; 11(9):1705. https://doi.org/10.3390/antiox11091705

Li, Yiqi, Yeli Li, Nana Chen, Linying Feng, Jianmei Gao, Nan Zeng, Zhixu He, and Qihai Gong. 2022. "Icariside II Exerts Anti-Type 2 Diabetic Effect by Targeting PPARα/γ: Involvement of ROS/NF-κB/IRS1 Signaling Pathway" Antioxidants 11, no. 9: 1705. https://doi.org/10.3390/antiox11091705

Li, Y., Li, Y., Chen, N., Feng, L., Gao, J., Zeng, N., He, Z., & Gong, Q. (2022). Icariside II Exerts Anti-Type 2 Diabetic Effect by Targeting PPARα/γ: Involvement of ROS/NF-κB/IRS1 Signaling Pathway. Antioxidants, 11(9), 1705. https://doi.org/10.3390/antiox11091705